Search

Alkermes PLC

Abrir

SetorSaúde

44.03 1.31

Visão Geral

Variação de preço das ações

24h

Atual

Mín

42.99

Máximo

44.62

Indicadores-chave

By Trading Economics

Rendimento

67M

501K

Vendas

103M

496M

P/E

Médio do Setor

113.079

49.241

EPS

0.52

Margem de lucro

0.101

Funcionários

2,050

EBITDA

76M

54M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+35.16% upside

Dividendos

By Acuity

Próximos Ganhos

3 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-1.6B

7.2B

Abertura anterior

42.72

Fecho anterior

44.03

Alkermes PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

22 de out. de 2026, 20:07 UTC

Alkermes Plc shares advanced, trading higher after Wednesday's close, despite pulling back from a session high earlier in the day.

21 de out. de 2026, 20:01 UTC

Alkermes Plc shares fell sharply after reaching an early high, declining to their lowest point before 3:30 PM.

20 de out. de 2026, 20:08 UTC

Alkermes Plc is trading higher, maintaining gains since Monday, despite pulling back from earlier session highs, and remains above its 20-day moving average.

19 de out. de 2026, 20:01 UTC

News

Piper Sandler reiterates Overweight rating on Alkermes and sets price target at $65 following management meetings.

17 de out. de 2026, 00:02 UTC

Alkermes Plc's shares advanced modestly in after-market trading on Friday, following three consecutive higher daily closes and a notable rise during the session.

16 de out. de 2026, 23:31 UTC

Alkermes Plc has advanced in after-market trading, reaching its highest level since Friday's close, continuing a stronger trend from recent sessions.

15 de out. de 2026, 20:01 UTC

Alkermes Plc shares are advancing, having gained since Wednesday's close, peaking nearly 4% earlier before pulling back slightly.

14 de out. de 2026, 20:07 UTC

Event

Alkermes plans to present two oral presentations and six posters at the European Sleep Research Society’s Congress in October 2026.

12 de out. de 2026, 19:16 UTC

Alkermes Plc shares fell, continuing a trend of weakness, and are positioned below their 20-day moving average near the lower end of their one-month range.

9 de out. de 2026, 21:51 UTC

Alkermes Plc is declining in after-market trading, reaching its lowest point since Friday's close and remaining significantly below its 20-day moving average.

8 de out. de 2026, 20:01 UTC

Alkermes Plc shares fell, reversing a trend of higher daily closes amid a broader shift in market performance.

7 de out. de 2026, 19:25 UTC

Alkermes Plc shares fell modestly, retracing from a late morning high, contributing to a lower performance since Tuesday's close and remaining below the 20-day moving average.

6 de out. de 2026, 19:51 UTC

Alkermes Plc shares fell sharply, continuing a notable decline since Monday's close amid broader market conditions and trading below its 20-day moving average.

5 de out. de 2026, 23:40 UTC

Alkermes Plc is trading higher in after-market hours, extending its upward trend after three consecutive sessions of gains amid positive biotechnology sector performance.

2 de out. de 2026, 19:26 UTC

Alkermes Plc is trading sharply higher, recovering from earlier lows, despite remaining below its 20-day moving average and near the lower end of its one-month range.

1 de out. de 2026, 22:50 UTC

Alkermes Plc declined in after-market trading, moving lower since Thursday's close and positioning the stock below its 20-day moving average.

29 de set. de 2026, 20:07 UTC

Alkermes Plc closed higher in Tuesday's trading session, despite notable volatility, finishing above Monday's close but below its 20-day moving average.

28 de set. de 2026, 19:16 UTC

News

Alkermes Plc shares fell modestly, continuing a decline since Friday and trading near the lower end of their one-month range.

24 de set. de 2026, 20:01 UTC

News

Alkermes Plc shares fell sharply as Goldman Sachs resumed coverage with a Neutral rating and a $50.00 price target, contributing to the stock's decline.

23 de set. de 2026, 20:07 UTC

Alkermes Plc shares fell sharply today, hitting a midday low and remaining below the 20-day moving average after earlier strength in the session.

22 de set. de 2026, 20:01 UTC

Event

Alkermes Plc reported positive results from a phase 1 study for ALKS 7290, yet shares fell sharply, remaining below their 20-day moving average.

21 de set. de 2026, 23:51 UTC

Event

Alkermes Plc's stock is declining in after-market trading despite positive phase 1 results for ALKS 7290, remaining below its 20-day moving average.

18 de set. de 2026, 20:02 UTC

Alkermes Plc shares fell sharply, reversing recent upward momentum, with a decline following a series of higher daily closes since Thursday's close.

17 de set. de 2026, 19:36 UTC

Alkermes Plc is trading higher, having previously peaked, but remains below its 20-day moving average and near the lower end of its one-month range.

15 de set. de 2026, 19:56 UTC

Alkermes Plc is trading higher today, with no specific news identified. Investor sentiment is influenced by expectations of a Federal Reserve rate hike.

14 de set. de 2026, 19:16 UTC

Alkermes Plc shares are lower amid negative market sentiment over inflation and supply chain issues, nearing the lower end of their one-month range.

11 de set. de 2026, 19:36 UTC

Alkermes shares are lower in Friday's session, lacking specific news. The broader market reacts to the Consumer Price Index release amid interest rate speculation.

10 de set. de 2026, 20:13 UTC

Alkermes Plc shares are lower in after-market trading, reflecting bearish sentiment amid the European Central Bank's interest rate hike and inflation concerns.

9 de set. de 2026, 20:07 UTC

Alkermes Plc shares are lower today, continuing a recent downward trend amid no specific news. The stock remains below its 20-day moving average.

8 de set. de 2026, 21:31 UTC

Alkermes Plc rose in after-market trading, gaining momentum despite broader market pressures and rising crude oil prices. No specific news was identified to explain the move.

Comparação entre Pares

Variação de preço

Alkermes PLC Previsão

Preço-alvo

By TipRanks

35.16% parte superior

Previsão para 12 meses

Média 58.769 USD  35.16%

Máximo 83 USD

Mínimo 38 USD

Com base em 14 analistas de Wall Street que oferecem metas de preço de 12 meses para Alkermes PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

14 ratings

10

Comprar

3

Manter

1

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Alkermes PLC

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS). The Company's products include ARISTADA, VIVITROL, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, TREVICTA, RISPERDAL CONSTA, AMPYRA, FAMPYRA, BYDUREON, Aripiprazole lauroxil, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, ALKS 4230 and ALKS 7119. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.
help-icon Live chat